AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

Rhea-AI Summary

AccuStem Sciences (OTCQB: ACUT), a clinical stage diagnostics company focused on cancer patient outcomes, has announced that Chairman of the Board Gabriele Cerrone has increased his stake in the company. Cerrone purchased an additional 8,991 shares of ACUT in the open market, bringing his total shareholding to 6,500,000 shares. This insider purchase by the Chairman demonstrates confidence in the company's direction and potential.

Positive

• Chairman's increased stake shows confidence in company's future
• Significant total holding of 6.5 million shares by Chairman indicates strong insider commitment

Negative

• None.

LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 8,991 ACUT shares in the open market. This brings his total holding to 6,500,000 shares.

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness,” we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making.
For more information, please visit www.accustem.com.

Investor and Media Contact:
Wendy Blosser
Email: investors@accustem.com

FAQ

How many ACUT shares did AccuStem Sciences Chairman purchase in June 2025?

AccuStem Sciences Chairman Gabriele Cerrone purchased 8,991 additional ACUT shares in the open market.

What is the total shareholding of AccuStem Sciences Chairman after the recent purchase?

After the recent purchase, Chairman Gabriele Cerrone's total shareholding in AccuStem Sciences (ACUT) is 6,500,000 shares.

Who is the Chairman of AccuStem Sciences (ACUT)?

Gabriele Cerrone is the Chairman of the Board of AccuStem Sciences.

What type of company is AccuStem Sciences (ACUT)?

AccuStem Sciences is a clinical stage diagnostics company focused on improving outcomes for cancer patients.